Evidence map›Paper›PMID 26415118›Full record

ArticlePsychoneuroendocrinology2016

Local oxytocin tempers anxiety by activating GABAA receptors in the hypothalamic paraventricular nucleus.

Adam S Smith, Manal Tabbaa, Kelly Lei, Patrick Eastham, Michael J Butler, Latanya Linton, Randy Altshuler, Yan Liu, Zuoxin Wang

Open access · greenAbstract read
In one paragraph

Article in Psychoneuroendocrinology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 110 citations in OpenAlex.

  1. Trial
  2. Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Trial
  3. Microbial lysate upregulates host oxytocin.Brain, behavior, and immunity · 2017
    Trial
  4. Article
  5. Review
  6. Review
  7. Article
  8. How does oxytocin modulate human behavior?Molecular psychiatry · 2025
    Review
  9. Article
  10. Article
  11. Neuropeptidergic systems in psychiatric disorders.Frontiers in endocrinology · 2025
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Adam S SmithDepartment of Psychology and Program in Neuroscience, Florida State University, Tallahassee, FL 32306, USA.
Manal TabbaaDepartment of Psychology and Program in Neuroscience, Florida State University, Tallahassee, FL 32306, USA.
Kelly LeiDepartment of Psychology and Program in Neuroscience, Florida State University, Tallahassee, FL 32306, USA.
Patrick EasthamDepartment of Psychology and Program in Neuroscience, Florida State University, Tallahassee, FL 32306, USA.
Michael J ButlerDepartment of Psychology and Program in Neuroscience, Florida State University, Tallahassee, FL 32306, USA.
Latanya LintonDepartment of Psychology and Program in Neuroscience, Florida State University, Tallahassee, FL 32306, USA.
Randy AltshulerDepartment of Psychology and Program in Neuroscience, Florida State University, Tallahassee, FL 32306, USA.
Yan LiuDepartment of Psychology and Program in Neuroscience, Florida State University, Tallahassee, FL 32306, USA.
Zuoxin WangDepartment of Psychology and Program in Neuroscience, Florida State University, Tallahassee, FL 32306, USA. Electronic address: zwang@psy.fsu.edu.
Florida State University · US

Funding

DOPAMINE REGULATION OF SOCIAL ATTACHMENTR01MH058616 · NIMH · FLORIDA STATE UNIVERSITY · PI WANG, ZUOXIN · 2000 to 2016
$3.7M
New Neurons in the Adult AmygdalaR01MH089852 · NIMH · FLORIDA STATE UNIVERSITY · PI WANG, ZUOXIN · 2010 to 2014
$1.8M
NIMH NIH HHS R01 MH058616NIMH NIH HHS R01 MH089852PHS HHS NIMHF31-095464PHS HHS NIMHR01-058616PHS HHS NIMHR01-89852
6 · The paper itself

Abstract

Oxytocin (Oxt) is released in various hypothalamic and extrahypothalamic brain areas in response to anxiogenic stimuli to regulate aspects of emotionality and stress coping. We examined the anxiolytic action of Oxt in the hypothalamic paraventricular nucleus (PVN) while appraising if Oxt recruits GABA neurons to inhibit the behavioral, hormonal, and neuronal response to stress in female prairie voles (Microtus ochrogaster). Voles received an injection of Oxt in the PVN either before or after an elevated platform stress to determine a time-course for the effects of Oxt on the hormonal stress response. Subsequently, we evaluated if ante-stress injections of Oxt affected anxiety-like behaviors as well as neuronal activity in the PVN, using real-time in-vivo retrodialysis and immunohistochemistry with c-Fos expression as a biomarker of neural activity. In addition, we exposed voles to Oxt and a GABAA receptor antagonist, concurrently, to evaluate the impact of pharmacological blockade of GABAA receptors on the anxiolytic effects of Oxt. Elevated platform stress amplified anxiety-like behaviors and hypothalamic-pituitary-adrenal (HPA) axis activity-catalyzing corticotrophin-releasing hormone (CRH) neuronal activity and augmenting corticosterone release in circulation. Ante-stress Oxt injections in the PVN blocked these stress effects while promoting PVN GABA activity and release. Post-stress Oxt treatments were ineffective. The anxiolytic effects of Oxt were hindered by concurrent pharmacological blockade of GABAA receptors. Together, our data demonstrate ante-stress treatments of Oxt in the PVN inhibit stress activation of the HPA axis through recruitment of GABAergic neurons, providing insights to the local circuitry and potential therapeutically-relevant mechanisms.

Indexed as

AnimalsAnxietyArvicolinaeBehavior, AnimalCorticosteroneCorticotropin-Releasing HormoneFemaleGABA-A Receptor AgonistsGABA-A Receptor AntagonistsHypothalamo-Hypophyseal SystemImmunohistochemistryMicrodialysisOxytocicsOxytocinParaventricular Hypothalamic NucleusPituitary-Adrenal SystemCorticosteroneCorticotropin-Releasing HormoneGABA-A Receptor AgonistsGABA-A Receptor AntagonistsOxytocicsOxytocinProto-Oncogene Proteins c-fosReceptors, GABA-ACorticotrophinreleasing hormoneGABAHypothalamic-pituitary-adrenal axisOxytocinPrairie voleRetrodialysis

Identifiers

PMID26415118
PMCPMC4695278
OpenAlexW2045447297

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.